BMS-303141, ATP citrate lyase (ACL) inhibitor, 5mg, CAS# 943962-47-8

BMS-303141, ATP citrate lyase (ACL) inhibitor, 5mg, CAS# 943962-47-8

NSC697923, Ubiquitin E2 Conjugating enzyme inhibitor, 25mg, CAS# 343351-67-7

NSC697923, Ubiquitin E2 Conjugating enzyme inhibitor, 25mg, CAS# 343351-67-7

ML239, Selective cancer stem cell killer, 5mg, CAS# 1378872-36-6

$65.00
(2,4,6-Trichlorophenoxy)-acetic acid (1H-pyrrol-2-ylmethylene)-hydrazide Purity: 98% by TLC Purity: NMr (Conforms) Store -20°C Ship RT (1 per EA )

Manufacturer: Focus Biomolecules

SKU
10-1417-5mg-EA
ML239, Selective cancer stem cell killer, 5mg, CAS# 1378872-36-6 is available to buy in increments of 1

Product Details

Download Details and Specifications

A novel inhibitor of the growth and proliferation of breast cancer stem cells (CSC) discovered in a phenotypic screen employing CSC-like cells produced by inducing human breast epithelial cells into an epithelial-to-mesenchymal transdifferentiated state (HMLE_sh_ECad). ML239 displayed an IC50=1.18 μM against HMLE_sh_ECad and demonstrated a >23-fold selectivity over control cells. It was also toxic to two other CSC-like lines1,2. Gene expression studies showed altered gene expression in the NFκB pathway1 and support activation of fatty acid desaturase 2 (FADS2) as a potential mechanism of action for ML239.3

CAS Number: 1378872-36-6

Manufacturer Part Number/SKU: 10-1417-5mg-EA

Tags: Focus Biomolecules